250 related articles for article (PubMed ID: 9009165)
21. Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.
Schnyder B; Lahm H; Woerly G; Odartchenko N; Ryffel B; Car BD
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):767-74. PubMed ID: 8645156
[TBL] [Abstract][Full Text] [Related]
22. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules.
Chen XH; Patel BK; Wang LM; Frankel M; Ellmore N; Flavell RA; LaRochelle WJ; Pierce JH
J Biol Chem; 1997 Mar; 272(10):6556-60. PubMed ID: 9045682
[TBL] [Abstract][Full Text] [Related]
23. Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Schumann RR; Nakarai T; Gruss HJ; Brach MA; von Arnim U; Kirschning C; Karawajew L; Ludwig WD; Renauld JC; Ritz J; Herrmann F
Blood; 1996 Mar; 87(6):2419-27. PubMed ID: 8630406
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases.
Yin T; Keller SR; Quelle FW; Witthuhn BA; Tsang ML; Lienhard GE; Ihle JN; Yang YC
J Biol Chem; 1995 Sep; 270(35):20497-502. PubMed ID: 7544789
[TBL] [Abstract][Full Text] [Related]
25. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
26. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons.
Burfoot MS; Rogers NC; Watling D; Smith JM; Pons S; Paonessaw G; Pellegrini S; White MF; Kerr IM
J Biol Chem; 1997 Sep; 272(39):24183-90. PubMed ID: 9305869
[TBL] [Abstract][Full Text] [Related]
27. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
28. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
30. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression.
Reichel M; Nelson BH; Greenberg PD; Rothman PB
J Immunol; 1997 Jun; 158(12):5860-7. PubMed ID: 9190938
[TBL] [Abstract][Full Text] [Related]
31. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.
Gooch JL; Christy B; Yee D
Neoplasia; 2002; 4(4):324-31. PubMed ID: 12082548
[TBL] [Abstract][Full Text] [Related]
32. Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation.
Wery-Zennaro S; Letourneur M; David M; Bertoglio J; Pierre J
FEBS Lett; 1999 Dec; 464(1-2):91-6. PubMed ID: 10611490
[TBL] [Abstract][Full Text] [Related]
33. Signaling pathway of ciliary neurotrophic factor in neuroblastoma cell lines.
Kuroda H; Sugimoto T; Horii Y; Sawada T
Med Pediatr Oncol; 2001 Jan; 36(1):118-21. PubMed ID: 11464862
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.
Lai SY; Molden J; Liu KD; Puck JM; White MD; Goldsmith MA
EMBO J; 1996 Sep; 15(17):4506-14. PubMed ID: 8887542
[TBL] [Abstract][Full Text] [Related]
35. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
36. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
37. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.
Rolling C; Treton D; Pellegrini S; Galanaud P; Richard Y
FEBS Lett; 1996 Sep; 393(1):53-6. PubMed ID: 8804422
[TBL] [Abstract][Full Text] [Related]
38. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes.
Brunn GJ; Falls EL; Nilson AE; Abraham RT
J Biol Chem; 1995 May; 270(19):11628-35. PubMed ID: 7744803
[TBL] [Abstract][Full Text] [Related]
39. Impaired interleukin 4 signaling in T helper type 1 cells.
Huang H; Paul WE
J Exp Med; 1998 Apr; 187(8):1305-13. PubMed ID: 9547341
[TBL] [Abstract][Full Text] [Related]
40. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1.
Haque SJ; Wu Q; Kammer W; Friedrich K; Smith JM; Kerr IM; Stark GR; Williams BR
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8563-8. PubMed ID: 9238016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
